A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors

NCT05193721 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: SHR-1901

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.